emerg
sever
acut
respiratori
syndrom
sar
result
sever
outbreak
worldwid
earli
test
diagnosi
alway
conclus
identifi
sar
suspect
patient
nucleocapsid
protein
np
predomin
viru
deriv
structur
protein
shed
high
amount
serum
nasopharyng
aspir
first
week
infect
part
effort
simpl
easi
use
immunoswab
method
develop
gener
panel
monoclon
antibodi
mab
bispecif
mab
chicken
polyclon
igi
antibodi
sarscov
nucleocapsid
protein
np
employ
mabbas
immunoswab
np
concentr
pgml
salin
pig
nasopharyng
aspir
pgml
rabbit
serum
detect
bsmabbas
immunoswab
detect
np
concentr
pgml
salin
pgml
rabbit
serum
pgml
pig
nasopharyng
aspir
polyclon
igybas
immunoswab
detect
np
concentr
pgml
pig
nasopharyng
aspir
provid
sensit
sar
point
care
assay
result
show
robust
immunoswab
method
detect
sarscov
np
antigen
develop
easi
effect
way
identifi
sar
suspect
individu
futur
sar
epidem
therebi
reduc
contain
transmiss
key
featur
simpl
immunoswab
diagnost
assay
abil
detect
presenc
sarscov
antigen
within
min
avail
bodi
fluid
sampl
potenti
lethal
variant
human
sarscov
emerg
guangdong
provinc
china
result
close
death
worldwid
peiri
et
al
poon
et
al
sporad
instanc
laboratori
sar
case
also
report
contain
sar
outbreak
normil
b
normil
vogel
includ
four
clinic
case
guangdong
provinc
liang
et
al
impact
sar
outbreak
affect
social
econom
activ
region
global
tan
et
al
led
world
wide
collabor
effort
analyz
viru
structur
patholog
rout
infect
possibl
diagnost
therapeut
intervent
common
mode
transmiss
sarscov
shown
infecti
respiratori
airborn
droplet
contribut
global
outbreak
b
develop
rapid
diagnost
procedur
detect
suspect
case
sar
infect
could
limit
clinic
nosocomi
infect
viral
nucleocapsid
protein
np
highli
phosphoryl
basic
antigen
aa
interact
membran
protein
chang
et
al
fang
et
al
luo
et
al
b
rota
et
al
make
viral
rna
nucleocapsid
chen
et
al
hsieh
et
al
huang
et
al
lai
np
also
predomin
viru
deriv
protein
throughout
infect
probabl
templat
mrna
abund
subgenom
rna
di
et
al
hiscox
et
al
lau
et
al
rota
et
al
make
viabl
target
diagnost
current
diagnosi
sarscov
depend
basic
laboratorybas
test
sinc
clinic
symptom
nonspecif
compar
respiratori
ill
caus
nonsar
pathogen
henc
develop
specif
method
detect
sarscov
viru
crucial
identif
prevent
futur
sar
outbreak
date
three
method
report
laboratori
detect
sarscov
viru
viru
isol
patient
sampl
inocul
cell
cultur
use
determin
presenc
infect
often
time
consum
tediou
prone
fals
result
keyaert
et
al
yamashita
et
al
b
convent
revers
transcriptas
polymeras
chain
reaction
rtpcr
use
direct
detect
viral
rna
labori
expens
requir
highli
skill
personnel
success
rate
identif
earli
infect
wu
et
al
c
serolog
detect
viral
antibodi
igg
igm
enzym
link
immunosorb
assay
elisa
immunofluoresc
ifa
western
blot
found
sensit
time
lag
detect
antibodi
week
make
method
less
viabl
earli
diagnosi
guan
et
al
saijo
et
al
yu
et
al
sar
high
rate
transmiss
mortal
rate
need
rapid
sensit
inexpens
detect
method
use
effect
quarantin
infect
person
clinic
therapeut
monitor
mitig
rapid
spread
infect
recent
studi
shown
sarscov
np
detect
acut
phase
sar
infect
specif
monoclon
antibodi
mab
che
et
al
huang
et
al
liu
et
al
shang
et
al
tan
et
al
woo
et
al
comparison
viral
marker
enzymeenhanc
chemiluminesc
immunoassay
eclia
show
np
could
detect
patient
sera
within
day
infect
gradual
decreas
time
studi
also
show
circul
shed
antigen
detect
also
use
varieti
viral
diseas
hiv
hepat
b
hepat
c
viral
hemorrhag
fever
cytomegaloviru
cano
et
al
object
studi
develop
sensit
immunoassay
util
panel
mab
bispecif
antibodi
bsmab
chicken
igi
polyclon
antibodi
sarscov
np
earli
screen
point
care
applic
igi
polyclon
antibodi
also
attract
sourc
develop
sensit
immunoassay
compar
mammalian
antibodi
cova
miyamoto
et
al
b
sunwoo
et
al
gener
bsmab
bifunct
immunoconjug
bear
two
differ
bind
site
paratop
sarscov
np
avoid
need
random
chemic
coupl
strategi
develop
bsmab
first
kind
sarscov
np
subsequ
use
part
immunoswab
assay
presenc
intrins
enzym
bind
activ
within
bsmab
make
use
tool
develop
specif
diagnost
sarscov
np
clean
background
fetal
bovin
serum
fb
purchas
paa
cell
cultur
compani
ontario
canada
streptomycinpenicillinglutamin
obtain
gibco
ny
usa
polyethylen
glycol
peg
hat
ht
supplement
goat
antimous
igg
conjug
horseradish
peroxidas
gamhrpo
bovin
serum
albumin
bsa
fluorescein
isothiocyan
fitc
tetramethylrhodamin
isothiocyan
tritc
horseradish
peroxidas
type
vi
protein
gagaros
long
chainsulfosuccinimidyl
nh
biotin
low
molecular
weight
dextran
sulphat
rabbit
antichicken
igyhrpo
sourc
sigma
st
loui
mo
usa
cell
strainer
collect
spleen
streptavidinhrpo
sthrpo
obtain
bd
bioscienc
pharmingen
usa
bag
obtain
biovectra
canada
tetramethylbenzidin
tmb
hydrogen
peroxid
h
detect
reagent
obtain
kpl
laboratori
gaithersburg
md
usa
slidealyz
r
dialysi
obtain
pierc
rockford
il
usa
pig
nasopharyng
aspir
obtain
surgic
medic
research
institut
smri
univers
alberta
help
dr
gustavo
zayaszamora
dr
malcolm
king
pool
rabbit
serum
obtain
health
scienc
laboratori
anim
servic
hsla
univers
alberta
calcium
algin
fiber
tip
ultra
fine
aluminum
applic
swab
obtain
fisher
scientif
usa
tetramethylbenzidin
tmb
stabil
substrat
hrp
obtain
promega
corpor
madison
usa
nonsteril
flat
bottom
elisa
plate
obtain
nunc
intern
maxisorp
rochest
ny
usa
steril
flat
bottom
cell
cultur
plate
product
hybridoma
clone
cell
cultur
flat
bottom
plate
well
cell
cultur
flask
cm
respect
obtain
corn
incorpor
ny
usa
fulllength
codon
optim
np
gene
clone
bacteri
express
vector
express
protein
purifi
e
coli
cultur
da
suresh
nonglycosyl
np
use
gener
antinp
mab
antinp
igi
screen
bsmab
develop
immunoswab
assay
week
old
femal
balbc
mice
immun
intraperiton
time
np
antigen
day
use
complet
incomplet
freund
adjuv
antigen
day
use
pb
ph
immun
respons
antigen
assess
measur
titer
polyclon
antibodi
mous
serum
use
indirect
elisa
mice
highest
titer
splenectom
day
last
antigen
inject
spleen
cell
fuse
myeloma
cell
ratio
use
wv
polyethylen
glycol
peg
accord
techniqu
describ
previous
kohler
milstein
shahhosseini
et
al
five
sarscov
antinp
mab
develop
character
unpublish
data
mab
use
gener
quadroma
subsequ
immunoswab
assay
develop
isotyp
mab
determin
use
specif
hrpoantibodi
sigma
usa
chicken
immun
recombin
np
antigen
obtain
npspecif
igi
load
egg
accord
publish
method
sunwoo
et
al
immun
hen
carri
np
equal
volum
freund
incomplet
adjuv
immun
singl
comb
white
leghorn
chicken
intramuscularli
booster
immun
given
week
initi
immun
egg
collect
daili
igi
purifi
egg
yolk
antibodi
titer
elisa
sunwoo
et
al
develop
immunoswab
assay
antihrpo
wellcharacter
rat
hybridoma
previous
select
drug
resist
make
sensit
aminopterin
hat
medium
cell
line
along
antinp
sarscov
mab
chosen
develop
quadroma
hybridoma
hybridoma
suresh
et
al
b
secret
monospecif
antihorseradish
peroxidas
hrpo
antibodi
obtain
late
dr
c
milstein
medic
research
council
molecular
biolog
cambridg
unit
kingdom
develop
antinpantihrpo
quadroma
involv
maintain
two
hybridoma
cell
line
antinp
antihrpo
logarithm
growth
phase
contain
rpmi
medium
fb
supplement
co
trypan
blue
stain
observ
cell
use
fusion
stock
solut
tetramethyl
rhodamin
isothiocyan
tritc
mgml
fluorescein
isothiocyan
fitc
mgml
dilut
ratio
use
work
solut
follow
step
report
earlier
follow
success
complet
quadroma
fusion
da
suresh
tang
et
al
briefli
cellsml
antinp
hybridoma
hybridoma
separ
resuspend
rpmi
ph
respect
antinp
hybridoma
label
tritc
red
fluoresc
cell
label
fitc
green
fluoresc
follow
min
incub
co
incub
hybridoma
cell
suspens
wash
mix
tube
centrifug
g
min
cell
pellet
ml
peg
ad
drop
drop
period
min
gentl
mix
upon
addit
peg
cell
suspens
place
co
incub
min
follow
addit
ml
fb
free
rpmi
medium
dilut
toxic
effect
peg
flow
cytometri
epic
elit
cell
sorter
coulter
corpor
hialeah
usa
argon
ion
nm
air
cool
laser
cross
cancer
institut
univers
alberta
use
sort
cell
dual
fluoresc
seed
cellwel
well
steril
tissu
cultur
plate
rpmi
contain
fb
plate
incub
co
clone
screen
twice
use
bridg
elisa
suresh
et
al
b
clone
quadroma
perform
base
limit
dilut
cultur
method
four
best
clone
fusion
chosen
undergo
reclon
time
select
posit
highli
specif
quadroma
secret
bsmab
sarscov
np
bridg
elisa
use
screen
procedur
day
quadroma
fusion
method
involv
coat
elisa
plate
sarscov
np
antigen
solid
phase
microtit
plate
incub
overnight
wash
pbst
phosphat
buffer
salin
ph
time
block
dialyz
bovin
serum
albumin
dbsa
pbst
wash
serial
dilut
neat
quadroma
supernat
ad
plate
incub
h
aliquot
dilut
dbsa
hrpo
ad
microtit
plate
follow
wash
step
final
tmb
substrat
ad
well
posit
quadroma
select
min
color
develop
plate
read
nm
v
max
elisa
plate
reader
rpmi
media
pb
use
blank
neg
control
well
without
np
antigen
hrpo
purif
done
new
novel
method
use
maminophenylboron
acid
agaros
column
apba
describ
bhatnagar
et
al
briefli
apba
column
satur
hrpo
captur
bsmab
along
monospecif
antihrpo
mab
elimin
monospecif
antinp
speci
follow
short
wash
procedur
bound
antibodi
elut
potassium
phosphat
buffer
contain
sorbitol
antinp
mab
biotinyl
use
long
arm
biotinaimdo
hexano
ester
mg
prote
purifi
five
antinp
mab
pb
ph
ad
long
chain
biotin
mgml
incub
room
temperatur
rt
h
glycin
ad
solut
kept
shaker
min
delo
et
al
solut
dialyz
slidealyz
pb
ph
overnight
develop
immunoswab
assay
involv
use
calcium
algin
tip
swab
aluminum
shaft
base
previou
publish
method
tang
et
al
point
tip
swab
use
coat
captur
antibodi
later
use
identif
np
differ
matric
discuss
next
section
fig
three
differ
matric
use
spike
np
antigen
heterosandwichbas
detect
normal
salin
ph
neat
rabbit
serum
use
spike
np
antigen
pig
nasopharyng
aspir
use
third
matrix
mimic
human
nasopharyng
aspiratebas
detect
endotrachi
tube
insert
nasopharynx
pig
sticki
mucou
process
modif
publish
method
sudo
et
al
aspir
suspend
low
molecular
weight
dextran
sulphat
mw
mgml
ratio
min
rt
suspend
mucou
centrifug
g
min
supernat
collect
spike
sarscov
np
antigen
develop
immunoswab
assay
differ
concentr
np
antigen
spike
salin
neat
rabbit
serum
pig
nasopharyng
aspir
aliquot
eppendorf
tube
tag
nasopharyng
calgiswab
incub
constant
volum
captur
antibodi
pb
ph
rt
min
dri
rt
min
fix
ethanol
min
dri
min
rt
swab
block
dbsa
min
rt
wash
pb
bsa
ph
time
simpl
fill
aspir
step
test
tube
wash
swab
incub
min
differ
concentr
np
antigen
spike
salin
neat
rabbit
serum
pig
nasopharyng
aspir
next
swab
wash
pb
incub
biotinyl
mab
igi
min
separ
eppendorf
tube
rt
bsmab
immunoswab
assay
bsmab
concentr
aliquot
dilut
pb
ph
use
swab
wash
pb
bsa
time
simpl
fill
aspir
method
test
tube
detect
biotinyl
murin
antibodi
chicken
igi
bound
antigen
done
incub
swab
sthrpo
dilut
dbsa
rabbit
antichicken
igyhrpo
dilut
dbsa
min
rt
howev
bsmab
assay
addit
hrpo
need
sinc
bsmab
alreadi
complex
hrpo
swab
care
wash
incub
tmb
substrat
color
develop
control
swab
also
incub
time
salin
rabbit
serum
pig
nasopharyng
aspir
without
np
antigen
digit
camera
high
pixel
size
optic
zoom
use
captur
imag
blue
color
shelflif
studi
robust
mab
bsmab
immunoswab
also
perform
three
differ
temperatur
rt
develop
antisarscov
np
hybridoma
accomplish
classic
hybridoma
technolog
recombin
np
antigen
express
e
coli
inject
balbc
mice
develop
antisarscov
np
mab
five
antisarscov
np
hybridoma
develop
name
primari
hybridoma
secret
antinp
antibodi
name
igg
igg
igg
fuse
antihrpo
hybridoma
gener
quadroma
proport
doubl
posit
cell
bispecif
fusion
rang
data
omit
reclon
process
involv
clone
quadroma
limit
dilut
one
cell
per
well
plate
quadroma
exhibit
polyploidi
henc
shown
high
level
instabl
process
repeat
reclon
help
obtain
identifi
strong
bsmab
secret
quadroma
three
quadroma
clone
select
base
high
optic
densiti
od
valu
tabl
bridg
elisa
suresh
et
al
b
tabl
od
valu
bsmab
increas
neat
cultur
supernat
initi
dilut
decreas
higher
dilut
purifi
yield
bsmab
cultur
supernat
later
util
develop
immunoswab
assay
chicken
igi
polyclon
antibodi
develop
sarscov
np
character
heterosandwich
assay
develop
use
differ
mab
captur
antibodi
igi
detector
antibodi
demonstr
five
mab
made
good
heterosandwich
best
heterosandwich
pair
use
captur
antibodi
igi
detector
antibodi
unpublish
data
best
pair
chosen
subsequ
immunoswab
assay
compar
test
immunoswab
assay
involv
detect
antigen
spike
differ
matric
salin
serum
pig
nasopharyng
aspir
simul
detect
np
antigen
done
understand
potenti
use
screen
applic
minim
train
person
perform
assay
futur
sar
outbreak
prepar
pig
nasopharyng
aspir
involv
use
dextran
sulphat
sudo
et
al
use
mucolyt
agent
break
coval
ionic
hydrogen
bond
exist
thick
mucou
gel
time
requir
perform
assay
set
swab
concentr
duplic
monoclon
polyclon
antibodi
approxim
min
bsmab
immunoswab
assay
design
swab
coat
mab
captur
np
follow
detect
bsmabhrpo
complex
time
requir
perform
assay
approxim
min
assay
time
reduc
bsmab
immunoswab
assay
compar
mab
igybas
detect
due
absenc
addit
wash
step
mabbas
assay
biotinyl
antibodi
need
addit
sthrpo
follow
wash
igybas
assay
addit
rabbit
antichicken
igyhrpo
follow
wash
step
assay
sensit
np
detect
differ
matric
also
vari
base
detect
mab
bsmab
igi
tabl
sensit
bsmab
high
salin
pgswab
pgml
compar
pgswab
pgml
seen
case
mabbas
immunoswab
assay
rabbit
serum
mab
bsmabbas
immunoswab
assay
show
sensit
pgswab
pgml
np
mab
bsmab
immunoswab
assay
sensit
np
pig
nasopharyng
aspir
pgml
pgswab
pgml
pgswab
respect
igi
immunoswab
assay
sensit
pgml
pgswab
higher
sensit
igi
compar
mab
bsmab
like
due
polyval
bind
np
antigen
detect
np
igi
immunoswab
perform
pig
nasopharyng
aspir
matrix
control
tube
without
np
antigen
show
color
assay
visual
qualiti
mabbas
immunoswab
rel
low
compar
bsmabbas
immunoswab
clear
background
fig
higher
sensit
due
high
specif
activ
molecular
uniform
bsmab
unlik
heterogen
chemic
conjug
sthrpo
complex
mab
immunoswab
assay
repeat
independ
time
concentr
duplic
perform
assay
similar
condit
show
good
concord
visual
sensit
mab
bsmab
swab
test
storag
week
time
period
understand
shelflif
differ
condit
pig
nasopharyng
aspir
use
surrog
human
sampl
test
visual
end
point
low
concentr
np
antigen
lowest
concentr
chosen
studi
pgml
pgswab
use
refer
point
np
sensit
also
lowest
level
np
detect
assay
initi
perform
mab
bsmabbas
detect
np
term
sensit
constant
week
three
storag
condit
detect
np
mab
bsmab
swab
store
rt
week
show
poorer
sensit
np
pgml
mabbas
detect
np
swab
store
week
sensit
pgml
compar
bsmabbas
detect
pgml
howev
detect
np
swab
store
week
mab
bsmab
immunoswab
assay
found
sensit
capabl
detect
pgml
week
pgml
np
could
detect
rt
mabbas
detect
exhibit
deterior
assay
comparison
bsmabbas
immunoswab
show
better
sensit
detect
np
week
pgml
pgml
rt
human
coronavirus
hcovnl
shown
caus
mild
upper
respiratori
tract
infect
rare
associ
lower
respiratori
tract
infect
elsahli
et
al
falsey
et
al
makela
et
al
case
sarscov
sever
lower
respiratori
tract
infect
seen
result
acut
respiratori
distress
syndrom
lo
et
al
fatal
rate
elderli
patient
holm
ksiazek
et
al
detect
np
demonstr
variou
bodi
fluid
suspect
sar
patient
includ
serum
urin
fecal
matter
nasopharyng
aspir
throat
wash
sampl
saliva
earli
day
infect
indic
np
rapidli
shed
high
amount
che
et
al
di
et
al
liu
et
al
wang
et
al
serum
pig
nasopharyng
aspir
select
studi
high
amount
shed
np
antigen
found
sar
infect
patient
mab
bsmab
igi
develop
compar
sensit
detect
np
point
care
applic
heterobifunct
bsmab
show
high
specif
activ
toward
np
bridg
elisa
antihrpo
bind
arm
conjug
hrpo
enzym
bsmab
also
reduc
time
cours
assay
show
excel
signal
nois
ratio
qualit
immunoswab
assay
recent
elisa
studi
report
sensit
recombin
np
pgml
use
polyclon
antibodi
pab
spike
human
sera
che
et
al
anoth
studi
rapid
immunochromatograph
test
rict
method
show
detect
np
pgml
nasopharyng
aspir
sampl
sar
patient
kogaki
et
al
comparison
mab
captur
np
follow
detect
bsmab
use
immunoswab
assay
show
np
detect
limit
pgml
pgswab
salin
pgml
pgswab
pig
nasopharyng
aspir
pgml
pgswab
rabbit
serum
tabl
like
np
could
partial
degrad
serum
matrix
mab
captur
np
detect
biotinyl
mab
show
sensit
limit
pgml
pgswab
salin
pig
nasopharyng
aspir
pgml
pgswab
rabbit
serum
igi
immunoswab
assay
format
sensit
pgml
pgswab
pig
nasopharyng
aspir
time
sensit
literatur
valu
kogaki
et
al
immunoswab
detect
sarscov
np
antigen
spike
salin
rabbit
serum
pig
nasopharyng
aspir
simpl
point
care
test
compar
elisa
ifa
di
et
al
set
swab
complet
min
mab
igi
format
min
bsmabbas
assay
rict
sar
assay
also
rapid
test
requir
train
personnel
oper
test
higher
cost
issu
underdevelop
part
world
contrast
immunoswab
assay
done
minim
train
person
low
cost
home
test
devic
futur
studi
robust
immunoswab
assay
shown
swab
precoat
captur
antibodi
util
week
decreas
sensit
np
detect
optim
longer
stabil
propos
extend
studi
human
mucu
pig
nasopharyng
aspir
intend
simul
aspir
sar
infect
patient
rel
eas
access
nasopharyng
aspir
patient
give
ad
advantag
test
within
short
period
time
futur
sar
outbreak
invas
procedur
term
sensit
mab
bsmab
swab
appear
show
good
bind
intens
color
follow
storag
rt
howev
yet
test
igi
immunoswab
shelflif
stabil
optim
effect
condit
stabil
assay
show
better
result
storag
mab
bsmab
immunoswab
sarscov
np
sequenc
share
low
amino
acid
homolog
human
coronavirus
also
report
mab
polyclon
antibodi
rais
sarscov
np
show
littl
crossreact
np
human
coronaviru
lau
et
al
nevertheless
propos
test
antibodi
develop
studi
potenti
crossreact
conclus
panel
mab
bsmab
igi
could
effect
use
sandwich
format
simpl
easytous
swab
detect
np
patient
bodi
fluid
clear
advantag
adopt
immunoswab
assay
clinic
primari
healthcar
set
first
eas
use
detect
highli
infect
strain
viru
could
help
rapid
detect
potenti
isol
patient
mitig
spread
infect
immunoswab
assay
could
util
simpl
rapid
point
care
diagnost
test
port
mass
human
entri
airport
seaport
bu
train
border
station
sinc
test
time
rapid
use
immunoswabbas
sarscov
detect
outbreak
unnecessarili
caus
inconveni
passeng
delay
travel
plan
success
type
assay
reduc
unpreced
paranoia
associ
outbreak
involv
peopl
travel
across
globe
type
test
also
use
popul
center
well
area
adequ
health
care
avail
main
advantag
test
low
costlow
tech
approach
use
immunoswab
also
requir
complic
technolog
highli
qualifi
staff
perform
test
social
worker
minim
train
use
test
primari
healthcar
rural
set
heavi
burden
peopl
underdevelop
countri
develop
countri
invest
costli
procedur
rtpcr
case
larg
outbreak
assay
particularli
use
part
world
lack
technolog
impedi
detect
sarscov
infect
diagnost
therapeut
procedur
procur
immunoswab
detect
np
also
set
preced
detect
viral
bacteri
diseas
avian
influenza
tuberculosi
diseas
similar
rout
air
born
infect
sarscov
also
shed
antigen
bodi
fluid
antinpantihrpo
bsmab
immunoswab
assay
detect
sarscov
mab
captur
np
detect
heterobifunct
bsmab
two
bind
site
one
bind
arm
paratop
bsmab
bind
np
arm
precomplex
hrpo
color
swab
pig
nasopharyng
aspir
medium
detect
np
taken
eppendorf
tube
captur
develop
blue
color
swab
imag
better
visual
reveal
increas
intens
color
increas
np
concentr
left
right
control
swab
test
absenc
antigen
show
color
develop
upon
addit
substrat
detect
limit
np
variou
matric
use
antinp
mab
immunoswab
assay
bsmab
assay
b
igi
assay
c
salin
n
rabbit
serum
n
pig
nasopharyng
aspir
n
b
salin
n
rabbit
serum
n
pig
nasopharyng
aspir
n
c
pig
nasopharyng
aspir
n
n
refer
separ
complet
independ
immunoswab
assay
batch
prepar
